Hemolytic disease of the newborn
Current as of: May 27, 2020
Author: Healthwise Staff
Medical Review: Adam Husney MD - Family Medicine & Sarah Marshall MD - Family Medicine & Kathleen Romito MD - Family Medicine & John Pope MD - Pediatrics
Hemolytic disease of the newbornHemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of a mother and her baby do not match. Substances (antibodies) in the mother's blood cross the placenta and may destroy the red blood cells of the fetus. After birth, a baby with hemolytic disease may be treated with a blood transfusion. Current as of: May 27, 2020 Author: Healthwise Staff Medical Review: Adam Husney MD - Family Medicine & Sarah Marshall MD - Family Medicine & Kathleen Romito MD - Family Medicine & John Pope MD - Pediatrics |
![]() |
Search the
Healthwise Knowledgebase This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. To learn more about Healthwise, visit Healthwise.org. © 1995-2020 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. |